Crowdonomics
This isn’t Regen BioPharma Inc’s most recent raise. Reg A+ · Equity · Nov 2025 (Open) is more current.View latest round
Regen BioPharma Inc

Section 4(a)(2) · Common Stock · Jun 2016

ClosedOtherCommon Equity
via the platform · last checked Sep 24, 2026
Raised
$934K
Investors
Estimated pre-money
$5.5M

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$5.5M
Price / share$0.0225
Price / share today$2.9095

Estimated, not stated: $0.0225 × 244,135,635 securities outstanding as of Apr 8, 2016 (Form 10-Q/A filed Mar 30, 2017, p. 1).

$0.0225 as sold; $2.9095 after the Dec 2022 conversion (11.600:1) and the Mar 2023 split (1:1500) (Form 10-Q, p. 1).

Offering details

Target
Max
Min investment
OpenedJun 28, 2016
Deadline
ClosedJun 26, 2017
Days active363

Links & provenance

Source: SEC EDGAR
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.